| 000 | 01220 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517211632.0 | ||
| 264 | 0 | _c20181102 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1532-2939 | ||
| 024 | 7 |
_a10.1016/j.jhin.2018.04.005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHurley, J C | |
| 245 | 0 | 0 |
_aParadoxical Acinetobacter-associated ventilator-associated pneumonia incidence rates within prevention studies using respiratory tract applications of topical polymyxin: benchmarking the evidence base. _h[electronic resource] |
| 260 |
_bThe Journal of hospital infection _cSep 2018 |
||
| 300 |
_a105-113 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcinetobacter Infections _xepidemiology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibiotic Prophylaxis _xmethods |
| 650 | 0 | 4 | _aBenchmarking |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aPneumonia, Ventilator-Associated _xepidemiology |
| 650 | 0 | 4 |
_aPolymyxins _xadministration & dosage |
| 773 | 0 |
_tThe Journal of hospital infection _gvol. 100 _gno. 1 _gp. 105-113 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhin.2018.04.005 _zAvailable from publisher's website |
| 999 |
_c28281677 _d28281677 |
||